$BLPG
Blue Line Protection Group, Inc. Stock $blpg

$blpg Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000149315224012110 Filed on April 01, 2024

Income Statement

Concept	2024 Q2	2023 Q4	2023
Revenue	$1.143M	$1.189M	$4.408M
YoY Change	3.5%	21.47%	13.73%
Cost Of Revenue	$418.7K	$425.0K	$1.542M
YoY Change	13.89%	25.35%	20.67%
Gross Profit	$724.4K	$763.8K	$2.866M
YoY Change	-1.69%	19.41%	10.31%
Gross Profit Margin	63.37%	64.25%	65.01%
Selling, General & Admin	$576.0K	$495.2K	$2.103M
YoY Change	2.89%	-41.73%	-16.45%
% of Gross Profit	79.52%	64.84%	73.39%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$19.89K	$51.70K	$251.7K
YoY Change	-40.59%	-24.85%	89.04%
% of Gross Profit	2.75%	6.77%	8.78%
Operating Expenses	$576.0K	$495.2K	$2.103M
YoY Change	2.89%	-41.73%	-16.45%
Operating Profit	$148.4K	$268.5K	$762.7K
YoY Change	-16.17%	-227.71%	843.49%
Interest Expense	-$280.5K	-$248.4K	-$412.5K
YoY Change	-605.98%	1137.42%	-311.94%
% of Operating Profit	-189.05%	-92.48%	-54.09%
Other Income/Expense, Net	-$280.5K		-$411.5K
YoY Change	508.72%		9.63%
Pretax Income	-$132.1K	$20.19K	$351.2K
YoY Change	-200.92%	-108.77%	-219.23%
Income Tax
% Of Pretax Income
Net Earnings	-$132.1K	$20.19K	$351.2K
YoY Change	-200.93%	-108.77%	-219.23%
Net Earnings / Revenue	-11.56%	1.7%	7.97%
Basic Earnings Per Share	$0.00		$0.04
Diluted Earnings Per Share	$0.00	$0.00	$0.04
COMMON SHARES
Basic Shares Outstanding	8.250M shares	8.250M shares	8.250M shares
Diluted Shares Outstanding	8.250M shares		10.93M shares

Balance Sheet

Concept	2024 Q2	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$821.7K	$585.8K	$585.8K
YoY Change	98.92%	109.15%	109.15%
Cash & Equivalents	$821.7K	$585.8K	$585.8K
Short-Term Investments
Other Short-Term Assets	$34.40K	$34.17K	$34.17K
YoY Change	2.38%	8.3%	8.3%
Inventory
Prepaid Expenses
Receivables	$328.4K	$368.4K	$368.4K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.185M	$988.3K	$988.3K
YoY Change	42.24%	44.32%	44.32%
LONG-TERM ASSETS
Property, Plant & Equipment	$219.3K	$840.8K	$840.8K
YoY Change	-74.0%	26.32%	26.85%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$31.74K	$31.74K	$31.74K
YoY Change	-8.53%	-8.53%	-8.53%
Total Long-Term Assets	$765.1K	$872.5K	$872.5K
YoY Change	-12.61%	25.09%	25.08%
TOTAL ASSETS
Total Short-Term Assets	$1.185M	$988.3K	$988.3K
Total Long-Term Assets	$765.1K	$872.5K	$872.5K
Total Assets	$1.950M	$1.861M	$1.861M
YoY Change	14.13%	34.61%	34.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$527.1K	$511.6K	$511.6K
YoY Change	-6.55%	-7.89%	-7.89%
Accrued Expenses	$147.7K	$121.5K	$121.5K
YoY Change	61.95%	8.26%	8.26%
Deferred Revenue
YoY Change
Short-Term Debt	$638.5K	$791.3K	$791.3K
YoY Change	-10.64%	4.52%	4.52%
Long-Term Debt Due	$152.8K	$22.02K	$22.02K
YoY Change	577.47%	-30.58%	-30.58%
Total Short-Term Liabilities	$2.170M	$1.950M	$1.950M
YoY Change	17.62%	2.23%	2.23%
LONG-TERM LIABILITIES
Long-Term Debt	$656.4K	$789.5K	$789.5K
YoY Change	-28.23%	-23.94%	-23.94%
Other Long-Term Liabilities	$420.6K	$494.2K	$494.2K
YoY Change	-29.06%	50.62%	50.62%
Total Long-Term Liabilities	$1.077M	$1.284M	$1.284M
YoY Change	-28.55%	-6.03%	-6.03%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.170M	$1.950M	$1.950M
Total Long-Term Liabilities	$1.077M	$1.284M	$1.284M
Total Liabilities	$3.247M	$3.234M	$3.234M
YoY Change	-3.14%	-1.22%	-1.22%
SHAREHOLDERS EQUITY
Retained Earnings	-$11.59M	-$11.61M
YoY Change	-2.12%	-2.93%
Common Stock	$8.251K	$8.251K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.298M	-$1.373M	-$1.373M
YoY Change
Total Liabilities & Shareholders Equity	$1.950M	$1.861M	$1.861M
YoY Change	14.13%	34.61%	34.61%

Cashflow Statement

Concept	2024 Q2	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$132.1K	$20.19K	$351.2K
YoY Change	-200.93%	-108.77%	-219.23%
Depreciation, Depletion And Amortization	$19.89K	$51.70K	$251.7K
YoY Change	-40.59%	-24.85%	89.04%
Cash From Operating Activities	$116.4K	$145.6K	$745.6K
YoY Change	30.27%	1223.18%	101.79%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$17.22K	$117.2K
YoY Change		15.96%	247.58%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00	-$17.22K	-$117.2K
YoY Change		15.96%	247.58%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-90.98K	-62.62K	-322.6K
YoY Change	6.26%	-30.7%	-55.06%
NET CHANGE
Cash From Operating Activities	116.4K	145.6K	745.6K
Cash From Investing Activities	0.000	-17.22K	-117.2K
Cash From Financing Activities	-90.98K	-62.62K	-322.6K
Net Change In Cash	25.43K	65.71K	305.7K
YoY Change	579.95%	-169.75%	-180.01%
FREE CASH FLOW
Cash From Operating Activities	$116.4K	$145.6K	$745.6K
Capital Expenditures	$0.00	$17.22K	$117.2K
Free Cash Flow	$116.4K	$128.3K	$628.3K
YoY Change	30.27%	-3433.25%	87.14%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001416697
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent		usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent		usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets		usd
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense		usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023	BLPG	Capitalized Leased Fixed Assets CapitalizedLeasedFixedAssets		usd
CY2022	BLPG	Initial Recognition Of Right Of Use Asset And Lease Liability InitialRecognitionOfRightOfUseAssetAndLeaseLiability		usd
CY2023	BLPG	Gain On Forgiveness Of Accrued Interest Related Party GainOnForgivenessOfAccruedInterestRelatedParty		usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited		usd
CY2023	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants		shares
CY2022	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants		shares
CY2022	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities		shares
CY2023Q4	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive		usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Security12g Title Security12gTitle	Common Stock, $0.001 par value
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	1144000	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	8250144	shares
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	dei	Auditor Name AuditorName	M&K CPAS, PLLC
CY2023	dei	Auditor Firm AuditorFirmId	2738
CY2023	dei	Auditor Location AuditorLocation	The Woodlands, TX
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	585780	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	280073	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	368352	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	373175	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	34174	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	31553	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	988306	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	684801	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	586620	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	408616	usd
CY2023Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	254171	usd
CY2022Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	254227	usd
CY2023Q4	us-gaap	Disposal Group Including Discontinued Operation Property Plant And Equipment DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment	2782	usd
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Property Plant And Equipment DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment	2782	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	843573	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	665625	usd
CY2023Q4	us-gaap	Security Deposit SecurityDeposit	28960	usd
CY2022Q4	us-gaap	Security Deposit SecurityDeposit	31920	usd
CY2023Q4	us-gaap	Assets Assets	1860839	usd
CY2022Q4	us-gaap	Assets Assets	1382346	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	511622	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	555445	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	22022	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	31719	usd
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	638500	usd
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	604256	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	121519	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	112250	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	503584	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	451119	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1950018	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1907560	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	15545	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	37568	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	494215	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	328116	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1283749	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1366184	usd
CY2023Q4	us-gaap	Liabilities Liabilities	3233767	usd
CY2022Q4	us-gaap	Liabilities Liabilities	3273744	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	20000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	20000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	20000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	20000000	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	20000	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	20000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	14000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	14000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8250144	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8250144	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8250144	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8250144	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	8251	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	8251	usd
CY2023Q4	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	129	shares
CY2022Q4	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	129	shares
CY2023Q4	BLPG	Common Stock Owed But Not Issued CommonStockOwedButNotIssued	13	usd
CY2022Q4	BLPG	Common Stock Owed But Not Issued CommonStockOwedButNotIssued	13	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	10213385	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	10046096	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-11614577	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-11965758	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-1372928	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-1891398	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1860839	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1382346	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4408311	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3876227	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	1542450	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	1278239	usd
CY2023	us-gaap	Gross Profit GrossProfit	2865861	usd
CY2022	us-gaap	Gross Profit GrossProfit	2597988	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2103148	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2517149	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	2103148	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	2517149	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	762713	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	80839	usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	1000	usd
CY2023	us-gaap	Interest Expense InterestExpense	242959	usd
CY2022	us-gaap	Interest Expense InterestExpense	194643	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-411532	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-375367	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	351181	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-294528	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8250144	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8398062	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8250144	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8398062	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10927179	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8398062	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10927179	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8398062	shares
CY2023	us-gaap	Net Income Loss NetIncomeLoss	351181	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-294528	usd
CY2023	us-gaap	Depreciation Depreciation	117272	usd
CY2022	us-gaap	Depreciation Depreciation	133146	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	134428	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	121095	usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	4750	usd
CY2023	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	50180	usd
CY2022	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	327596	usd
CY2023	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	169573	usd
CY2022	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	180724	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-4823	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	45133	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-339	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	137	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	54814	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	67224	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-137064	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-125266	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	745546	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	369471	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	117216	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	33725	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-117216	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-33725	usd
CY2023	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	64392	usd
CY2022	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	313318	usd
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	226512	usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	359244	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	31719	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	45288	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-322623	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-717850	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	305707	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-382104	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	280073	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	662177	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	585780	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	280073	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	181318	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	56204	usd
CY2022	BLPG	Capitalized Leased Fixed Assets CapitalizedLeasedFixedAssets	68872	usd
CY2023	BLPG	Derivative Resolution DerivativeResolution	117109	usd
CY2022	BLPG	Derivative Resolution DerivativeResolution	442389	usd
CY2023	BLPG	Initial Recognition Of Right Of Use Asset And Lease Liability InitialRecognitionOfRightOfUseAssetAndLeaseLiability	312432	usd
CY2022	BLPG	Gain On Forgiveness Of Accrued Interest Related Party GainOnForgivenessOfAccruedInterestRelatedParty	250000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-2621605	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	4750	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	327596	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	250000	usd
CY2022	BLPG	Adjustments To Additional Paid In Capital Derivative Resolution AdjustmentsToAdditionalPaidInCapitalDerivativeResolution	442389	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-294528	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-1891398	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-1891398	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	50180	usd
CY2023	BLPG	Adjustments To Additional Paid In Capital Derivative Resolution AdjustmentsToAdditionalPaidInCapitalDerivativeResolution	117109	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	351181	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-1372928	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-1372928	usd
CY2023	us-gaap	Revenues Revenues	4408311	usd
CY2006Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2006Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q2	us-gaap	Stockholders Equity Note Stock Split StockholdersEquityNoteStockSplit	On May 6, 2014, the Company effected a forward stock split and a pro-rata increase in its authorized common stock on a basis of 14-to-1, whereby each shareholder received 14 newly issued shares of common stock for each 1 share held.
CY2014Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1400000000	shares
CY2021Q3	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-100
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	14000000	shares
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_841_eus-gaap--UseOfEstimates_z3cTOOdiRYyg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_864_zuA0aOeDEecl">Use of estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	335780	usd
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2023Q4	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	503584	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	503584	usd
CY2022Q4	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	451119	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	451119	usd
CY2023	us-gaap	Depreciation Depreciation	117272	usd
CY2022	us-gaap	Depreciation Depreciation	133146	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_846_eus-gaap--ConcentrationRiskCreditRisk_zJe7bVtVV9ha" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86E_zF4JqjPs60Db">Concentration of business and credit risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has no significant off-balance sheet risks such as foreign exchange contracts, option contracts or other hedging arrangements. The Company’s financial instruments that are exposed to concentration of credit risks consist primarily of cash. The Company maintains its cash in bank accounts, which may at times, exceed federally insured limits.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company had one major customer which generated <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__srt--MajorCustomersAxis__custom--OneMajorCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zQMna4stXrEi" title="Concentration credit risk, percentage">9.75</span>% of total revenue in the year ended December 31, 2023 and three customers comprised <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__srt--MajorCustomersAxis__custom--ThreeCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z1tIUFX0fbae" title="Concentration credit risk, percentage">32</span>% of the account receivable balance at December 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company had one major customer which generated <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--OneMajorCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zi9g5GiPkxH8" title="Concentration credit risk, percentage">16</span>% of total revenue in the year ended December 31, 2022 and one customer comprised <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--OneCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zOMpJqa5JTC" title="Concentration credit risk, percentage">22</span>% of the account receivable balance at December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p>
CY2022	us-gaap	Revenues Revenues	3876227	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	5527	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	9808	usd
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3125000	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3022000	shares
CY2023	us-gaap	Net Income Loss NetIncomeLoss	351181	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-294528	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8250144	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8398062	shares
CY2023	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	2677035	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10927179	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8398062	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2023Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	34346	usd
CY2022Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	34346	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	21588012	usd
CY2022Q1	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	12500	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	21843180	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	19758466	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	8569392	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	3614880	usd
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	75373930	usd
CY2023Q4	BLPG	Operating Right Of Use Assets Lease OperatingRightOfUseAssetsLease	586620	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	586620	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	121519	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	494215	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	615734	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P42Y6M
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.12	pure
CY2023	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	134428	usd
CY2023	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	67184	usd
CY2023	BLPG	Finance Lease Expense FinanceLeaseExpense	201612	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	137064	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	218833	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	224230	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	193112	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	88179	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	37197	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	761551	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	145817	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	615734	usd
CY2022Q4	BLPG	Operating Right Of Use Assets Lease OperatingRightOfUseAssetsLease	408616	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	408616	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	112250	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	328116	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	440366	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y6M
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.12	pure
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	121095	usd
CY2022	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	6673	usd
CY2022	BLPG	Finance Lease Expense FinanceLeaseExpense	127768	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	125266	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1030351	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	958660	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	776180	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	704433	usd
CY2023Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	254171	usd
CY2022Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	254227	usd
CY2023Q4	us-gaap	Disposal Group Including Discontinued Operation Property Plant And Equipment DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment	2782	usd
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Property Plant And Equipment DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment	2782	usd
CY2023	us-gaap	Depreciation Depreciation	117272	usd
CY2022	us-gaap	Depreciation Depreciation	133146	usd
CY2022Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	137500	usd
CY2021Q3	us-gaap	Stock Issued During Period Shares Reverse Stock Splits StockIssuedDuringPeriodSharesReverseStockSplits	1570	shares
CY2022Q3	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	137500	usd
CY2022Q3	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.075	pure
CY2022Q3	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.075	pure
CY2022Q3	BLPG	Accrued Interest Debt Forgive AccruedInterestDebtForgive	250000	usd
CY2022Q3	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.075	pure
CY2022Q3	BLPG	Default Rate Percentage DefaultRatePercentage	0.12	pure
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	712784	usd
CY2022	BLPG	Settlement Of Derivatives Upon Conversion SettlementOfDerivativesUponConversion	-442389	usd
CY2022	us-gaap	Derivative Fair Value Hedge Included In Effectiveness Gain Loss DerivativeFairValueHedgeIncludedInEffectivenessGainLoss	180724	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	451119	usd
CY2023	BLPG	Settlement Of Derivatives Upon Conversion SettlementOfDerivativesUponConversion	-117109	usd
CY2023	us-gaap	Derivative Fair Value Hedge Included In Effectiveness Gain Loss DerivativeFairValueHedgeIncludedInEffectivenessGainLoss	169573	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	503584	usd
CY2014Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2014Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2014Q2	us-gaap	Stockholders Equity Note Stock Split StockholdersEquityNoteStockSplit	On May 6, 2014, the Company effected a forward stock split and a pro-rata increase in its authorized common stock on a basis of 14-to-1, whereby each shareholder received 14 newly issued shares of common stock for each 1 share held.
CY2014Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1400000000	shares
CY2021Q3	us-gaap	Stockholders Equity Note Stock Split StockholdersEquityNoteStockSplit	On July 6, 2021, the Company effected a reverse stock split and a pro-rata decrease in its authorized common stock on a basis of 1-for-100, the authorized capital of the Company concurrently decreased to 14,000,000 shares of common stock
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	14000000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3022000	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	350000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.21
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	50000	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0.21
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3332000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.21
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1713500	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.21
CY2023	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	0.21
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	3332000	shares
CY2023	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P3Y9M
CY2023Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	0.21
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	1713500	shares
CY2023Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	0.21
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	50180	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	327596	usd
CY2017Q4	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0.80	pure
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1759126	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1861158	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1759126	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1861158	usd

Files In Submission

Name	View Source	Status
0001493152-24-012110-index-headers.html	Edgar Link	pending
0001493152-24-012110-index.html	Edgar Link	pending
0001493152-24-012110.txt	Edgar Link	pending
0001493152-24-012110-xbrl.zip	Edgar Link	pending
blpg-20231231.xsd	Edgar Link	pending
ex19.htm	Edgar Link	pending
ex31.htm	Edgar Link	pending
ex32.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
form10-k_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
blpg-20231231_def.xml	Edgar Link	unprocessable
blpg-20231231_lab.xml	Edgar Link	unprocessable
blpg-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
blpg-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BLPG
Blue Line Protection Group, Inc. Stock $blpg

2024 Q2 Form 10-K Financial Statement

#000149315224012110 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BLPG Blue Line Protection Group, Inc. Stock $blpg

2024 Q2 Form 10-K Financial Statement

#000149315224012110 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BLPG
Blue Line Protection Group, Inc. Stock $blpg